452 related articles for article (PubMed ID: 23627196)
1. Favourable outcome in a patient bitten by a rabid bat infected with the European bat lyssavirus-1.
Van Gucht S; Verlinde R; Colyn J; Vanderpas J; Vanhoof R; Roels S; Francart A; Brochier B; Suin V
Acta Clin Belg; 2013; 68(1):54-8. PubMed ID: 23627196
[TBL] [Abstract][Full Text] [Related]
2. First isolation of a rabid bat infected with European bat lyssavirus in Luxembourg.
Servat A; Herr J; Picard-Meyer E; Schley L; Harbusch C; Michaux C; Pir J; Robardet E; Engel E; Cliquet F
Zoonoses Public Health; 2015 Feb; 62(1):7-10. PubMed ID: 24373212
[TBL] [Abstract][Full Text] [Related]
3. [Postexposure prophylaxis after bite of a broad-winged bat with evidence of European bat lyssavirus 1 (EBLV-1)].
Fasse J; Trawinski H; Hardt M; Lübbert C
Inn Med (Heidelb); 2024 Jun; 65(6):608-611. PubMed ID: 38100072
[TBL] [Abstract][Full Text] [Related]
4. Cross-Protection of Inactivated Rabies Vaccines for Veterinary Use against Bat Lyssaviruses Occurring in Europe.
Servat A; Wasniewski M; Cliquet F
Viruses; 2019 Oct; 11(10):. PubMed ID: 31614675
[TBL] [Abstract][Full Text] [Related]
5. Rabies prophylaxis in Western Australia: the impact of Australian bat lyssavirus.
Torvaldsen S; Watson T
Commun Dis Intell; 1998 Aug; 22(8):149-52. PubMed ID: 9735544
[TBL] [Abstract][Full Text] [Related]
6. Bat rabies surveillance in Europe.
Schatz J; Fooks AR; McElhinney L; Horton D; Echevarria J; Vázquez-Moron S; Kooi EA; Rasmussen TB; Müller T; Freuling CM
Zoonoses Public Health; 2013 Feb; 60(1):22-34. PubMed ID: 22963584
[TBL] [Abstract][Full Text] [Related]
7. Serological Survey of Lyssaviruses in Polish Bats in the Frame of Passive Rabies Surveillance Using an Enzyme-Linked Immunosorbent Assay.
Orłowska A; Smreczak M; Freuling CM; Müller T; Trębas P; Rola J
Viruses; 2020 Feb; 12(3):. PubMed ID: 32121200
[No Abstract] [Full Text] [Related]
8. Current Rabies Vaccines Do Not Confer Protective Immunity against Divergent Lyssaviruses Circulating in Europe.
Echevarría JE; Banyard AC; McElhinney LM; Fooks AR
Viruses; 2019 Sep; 11(10):. PubMed ID: 31554170
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of rabies vaccines in dogs and cats and protection in a mouse model against European bat lyssavirus type 2.
Nokireki T; Jakava-Viljanen M; Virtala AM; Sihvonen L
Acta Vet Scand; 2017 Oct; 59(1):64. PubMed ID: 28969696
[TBL] [Abstract][Full Text] [Related]
10. [A new case of bat rabies in France].
Delbos V; Abgueguen P; Chennebault JM; Pichard E
Rev Med Interne; 2006 Jul; 27(7):575-7. PubMed ID: 16797796
[TBL] [Abstract][Full Text] [Related]
11. Bat Bites and Rabies PEP in the Croatian Reference Centre for Rabies 1995-2020.
Vodopija R; Lojkić I; Hamidović D; Boneta J; Primorac D
Viruses; 2024 May; 16(6):. PubMed ID: 38932168
[TBL] [Abstract][Full Text] [Related]
12. Isolation, antigenicity and immunogenicity of Lleida bat lyssavirus.
Banyard AC; Selden D; Wu G; Thorne L; Jennings D; Marston D; Finke S; Freuling CM; Müller T; Echevarría JE; Fooks AR
J Gen Virol; 2018 Dec; 99(12):1590-1599. PubMed ID: 29745870
[TBL] [Abstract][Full Text] [Related]
13. Australian bat lyssavirus infection in three fruit bats from north Queensland.
Speare R; Skerratt L; Foster R; Berger L; Hooper P; Lunt R; Blair D; Hansman D; Goulet M; Cooper S
Commun Dis Intell; 1997 May; 21(9):117-20. PubMed ID: 9145563
[TBL] [Abstract][Full Text] [Related]
14. Incursion of European Bat Lyssavirus 1 (EBLV-1) in Serotine Bats in the United Kingdom.
Folly AJ; Marston DA; Golding M; Shukla S; Wilkie R; Lean FZX; Núñez A; Worledge L; Aegerter J; Banyard AC; Fooks AR; Johnson N; McElhinney LM
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696409
[TBL] [Abstract][Full Text] [Related]
15. Isolation and Characterization of Cross-Reactive Human Monoclonal Antibodies That Potently Neutralize Australian Bat Lyssavirus Variants and Other Phylogroup 1 Lyssaviruses.
Weir DL; Coggins SA; Vu BK; Coertse J; Yan L; Smith IL; Laing ED; Markotter W; Broder CC; Schaefer BC
Viruses; 2021 Mar; 13(3):. PubMed ID: 33804519
[TBL] [Abstract][Full Text] [Related]
16. Potential Exposures to Australian Bat Lyssavirus Notified in Queensland, Australia, 2009-2014.
Si D; Marquess J; Donnan E; Harrower B; McCall B; Bennett S; Lambert S
PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005227. PubMed ID: 28033365
[TBL] [Abstract][Full Text] [Related]
17. Utilisation of Chimeric Lyssaviruses to Assess Vaccine Protection against Highly Divergent Lyssaviruses.
Evans JS; Wu G; Selden D; Buczkowski H; Thorne L; Fooks AR; Banyard AC
Viruses; 2018 Mar; 10(3):. PubMed ID: 29543715
[TBL] [Abstract][Full Text] [Related]
18. European bat lyssaviruses: an emerging zoonosis.
Fooks AR; Brookes SM; Johnson N; McElhinney LM; Hutson AM
Epidemiol Infect; 2003 Dec; 131(3):1029-39. PubMed ID: 14959767
[TBL] [Abstract][Full Text] [Related]
19. First encounter of European bat lyssavirus type 2 (EBLV-2) in a bat in Finland.
Jakava-Viljanen M; Lilley T; Kyheröinen EM; Huovilainen A
Epidemiol Infect; 2010 Nov; 138(11):1581-5. PubMed ID: 20196902
[TBL] [Abstract][Full Text] [Related]
20. European bat lyssaviruses, The Netherlands.
Van der Poel WH; Van der Heide R; Verstraten ER; Takumi K; Lina PH; Kramps JA
Emerg Infect Dis; 2005 Dec; 11(12):1854-9. PubMed ID: 16485470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
